Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage Efferocytosis in Cardiac Pathophysiology and Repair. | Shock | 2021 | 32694395 | PubTator, text mining | PubMed |
| Enhanced metastable state models of TAM kinase binding to cabozantinib explains the dynamic nature of receptor tyrosine kinases. | J Biomol Struct Dyn | 2021 | 32070235 | PubTator, text mining | PubMed |
| Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade. | Cancer Drug Resist | 2020 | 35582229 | PubTator, text mining | PubMed |
| Choreography of methylation: KDM4C histone demethylation enables ALKBH5 m6A RNA demethylation to sustain AML stem cells. | Blood Sci | 2020 | 35400023 | PubTator, text mining | PubMed |
| A dual MET/AXL small-molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironment. | MedComm (2020) | 2020 | 34766112 | PubTator, text mining | PubMed |
| Chloroquine Cardiotoxicity Leading to Cardiogenic Shock. | JACC Case Rep | 2020 | 34317176 | PubTator, text mining | PubMed |
| Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response. | Front Oncol | 2020 | 33747899 | PubTator, text mining | PubMed |
| "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. | Front Oncol | 2020 | 33718121 | PubTator, text mining | PubMed |
| Case Report: Therapeutic Response to Chemo-Immunotherapy in an Advanced Large Cell Lung Carcinoma Patient With Low Values of Multiple Predictive Biomarkers. | Front Immunol | 2020 | 33584678 | PubTator, text mining | PubMed |
| Metformin and ovarian cancer: the evidence. | Ann Transl Med | 2020 | 33490223 | PubTator, text mining | PubMed |
| Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold. | RSC Med Chem | 2020 | 33479617 | PubTator, text mining | PubMed |
| The role of c-MET inhibitors in advanced hepatocellular carcinoma: now and future. | Ann Transl Med | 2020 | 33437816 | PubTator, text mining | PubMed |
| Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer. | J Immunother Cancer | 2020 | 33427690 | PubTator, text mining | PubMed |
| Emerging Functions of ICAM-1 in Macrophage Efferocytosis and Wound Healing. | J Cell Immunol | 2020 | 33426539 | PubTator, text mining | PubMed |
| BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/β-Catenin Pathway in Gastric Cancer. | Biomed Res Int | 2020 | 33426068 | PubTator, text mining | PubMed |
| A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted Activity. | Front Oncol | 2020 | 33425754 | PubTator, text mining | PubMed |
| Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives. | Cancers (Basel) | 2020 | 33396795 | PubTator, text mining | PubMed |
| Selecting Aragonez Genotypes Able to Outplay Climate Change-Driven Abiotic Stress. | Front Plant Sci | 2020 | 33391310 | PubTator, text mining | PubMed |
| Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment. | Front Oncol | 2020 | 33381449 | PubTator, text mining | PubMed |
| MicroRNA 34a-AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells. | Genes (Basel) | 2020 | 33374832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=60